# Patient Care Plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Vincent van Gogh (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI010-SYN
- Date: 2026-01-19
- Fictional facility: St. Posthumous Health Center
- Fictional author: Elise Verhoeven, MD
- Calendar frame: modern shifted

## What we are working on

- He wants to understand what happened to him and to stop it happening again, and is frightened that it will **S**
- He wants to paint every day again and to be able to concentrate **S**
- He is worried about his drinking and his sleep **S**

## Your goals

- No return of psychotic symptoms and no readmission through six months, on the lowest effective antipsychotic dose. Target: 2026-07-20. Recorded outcome: No psychotic symptoms since the six-week visit and no admission; aripiprazole 10 mg daily. **S**
- PHQ-9 score below 5 by six months. Target: 2026-07-20. Recorded outcome: PHQ-9 3. **S**
- Reduce drinking to PEth below 20 ng/mL by six months. Target: 2026-07-20. Recorded outcome: PEth 16 ng/mL from 284. **S**
- Weight gain under 5% and normal glucose, A1c and lipids at the 12-week check. Target: 2026-04-20. Recorded outcome: Weight 65.7 kg from 64.0 (2.7%); fasting glucose 94 mg/dL, A1c 5.4%, lipids normal. **S**
- Sleep about seven hours on most nights with regular times by three months. Target: 2026-04-20. Recorded outcome: Seven hours on most nights, in bed by midnight. **S**

## What we agreed to do

- Continue the antipsychotic started in hospital at the lowest effective dose, with side-effect checks at each visit (akathisia, stiffness, sedation) and monitoring to the APA and ADA/APA standard: weight at every visit, blood pressure, fasting glucose, A1c and lipids at baseline, 12 weeks and yearly, and the AIMS at baseline and every six months. Guideline: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition (2020); Consensus development conference on antipsychotic drugs and obesity and diabetes (2004); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**
- Psychiatry consultation with the first-episode psychosis coordinated specialty care team to review the provisional diagnosis and differential, the dose, the alcohol plan, and the workup for epilepsy. Guideline: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition (2020); Recovery After an Initial Schizophrenia Episode (RAISE): coordinated specialty care for first-episode psychosis (2026) **S**
- First-episode workup: blood count, metabolic panel, liver tests, thyroid test, vitamin B12, HIV and syphilis tests, urine drug test, brain MRI, and a sleep-deprived EEG because of the confusion and the question of seizures. Guideline: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition (2020) **S**
- Alcohol care: AUDIT-C, PEth at each check to follow drinking, brief counseling with goals he chooses, thiamine, and a medicine for alcohol use disorder once the liver tests are reviewed. Guideline: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition (2020); VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders (2021); Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions (2018) **S**
- Coordinated specialty care: a care coordinator, individual resilience-focused therapy, education about psychosis for him and for the people he chooses, support to return to painting and selling his work, and a peer specialist. Guideline: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition (2020); Recovery After an Initial Schizophrenia Episode (RAISE): coordinated specialty care for first-episode psychosis (2026) **S**
- Sleep as treatment and as an early warning sign: regular sleep and wake times, no alcohol to get to sleep, less coffee after noon, and a plan to call the team after two nights of short sleep. Guideline: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition (2020); Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder (2018) **S**
- Structured safety assessment, a written safety plan with early warning signs, lethal-means counseling, the 988 Suicide & Crisis Lifeline, PHQ-9 at each visit, and safety review at every visit. Guideline: Depression and Suicide Risk in Adults: Screening (2023); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026) **S**
- Akathisia: aripiprazole back to 10 mg daily, propranolol 10 mg twice daily for a few weeks, and a check of restlessness and of safety at each visit until it settles. Guideline: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition (2020) **S**

## Follow-up

- 2026-01-19: Establishing primary care twelve days after discharge from a first psychiatric admission: provisional diagnosis, antipsychotic monitoring baseline, first-episode workup, alcohol, sleep, and safety planning **S**
- 2026-02-02: Two-week review and psychiatry consultation with the coordinated specialty care team **S**
- 2026-03-02: Six-week review: symptoms, side effects, alcohol, sleep, and test results **S**
- 2026-04-20: Three-month review with the 12-week metabolic check **S**
- 2026-06-15: Periodic adult preventive visit **S**
- 2026-07-20: Six-month review: diagnosis, relapse prevention, movement check, and alcohol **S**

This teaching document does not replace care from a qualified clinician.
